Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Gilbert

Showing results (31-40 of 453) with videos related to

Pageof 46
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2006
Diffusely infiltrative low-grade gliomas in adultsFrederick F Lang, Mark R Gilbert
Therapeutics and Clinical Risk Management|June 3, 2008
Management of patients with newly diagnosed malignant primary brain tumors with a focus on the evolving role of temozolomideMark R Gilbert, Terri S Armstrong
Neuro-Oncology|October 26, 2012
Practical strategies for management of fatigue and sleep disorders in people with brain tumorsTerri S Armstrong, Mark R Gilbert
F1000Prime Reports|July 4, 2014
Advances in treating glioblastomaShiao-Pei Weathers, Mark R Gilbert
Neuro-Oncology|November 2, 2021
Clinical trial challenges, design considerations, and outcome measures in rare CNS tumorsTerri S Armstrong, Mark R Gilbert
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Anaplastic oligodendroglial tumors: a tale of two trialsMark R Gilbert, Frederick F Lang
Neurologic Clinics|October 30, 2007
Management of patients with low-grade gliomasMark R Gilbert, Frederick F Lang
Expert Opinion on Pharmacotherapy|August 28, 2004
The treatment of neoplastic meningitisTerri S Armstrong, Mark R Gilbert
Journal of Neuro-Oncology|January 12, 2015
Current challenges in designing GBM trials for immunotherapyShiao-Pei Weathers, Mark R Gilbert
Current Oncology Reports|December 14, 2006
Net clinical benefit: functional endpoints in brain tumor clinical trialsTerri S Armstrong, Mark R Gilbert
Pageof 46

Showing results (31-40 of 453) with videos related to

Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2006
Diffusely infiltrative low-grade gliomas in adultsFrederick F Lang, Mark R Gilbert
Therapeutics and Clinical Risk Management|June 3, 2008
Management of patients with newly diagnosed malignant primary brain tumors with a focus on the evolving role of temozolomideMark R Gilbert, Terri S Armstrong
Neuro-Oncology|October 26, 2012
Practical strategies for management of fatigue and sleep disorders in people with brain tumorsTerri S Armstrong, Mark R Gilbert
F1000Prime Reports|July 4, 2014
Advances in treating glioblastomaShiao-Pei Weathers, Mark R Gilbert
Neuro-Oncology|November 2, 2021
Clinical trial challenges, design considerations, and outcome measures in rare CNS tumorsTerri S Armstrong, Mark R Gilbert
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Anaplastic oligodendroglial tumors: a tale of two trialsMark R Gilbert, Frederick F Lang
Neurologic Clinics|October 30, 2007
Management of patients with low-grade gliomasMark R Gilbert, Frederick F Lang
Expert Opinion on Pharmacotherapy|August 28, 2004
The treatment of neoplastic meningitisTerri S Armstrong, Mark R Gilbert
Journal of Neuro-Oncology|January 12, 2015
Current challenges in designing GBM trials for immunotherapyShiao-Pei Weathers, Mark R Gilbert
Current Oncology Reports|December 14, 2006
Net clinical benefit: functional endpoints in brain tumor clinical trialsTerri S Armstrong, Mark R Gilbert
Pageof 46